SDS
Sentinel 811 Multi-Surface Adhesive Primer
Safety Data Sheet
Prepared according to Federal Register / Vol. 77, No. 58 / Monday, March 26, 2012 / Rules and Regulations
08/18/2015
Sentinel 811 Multi-Surface Adhesive
Primer
4/6
10.2. Chemical stability
Stable under recommended handling and storage conditions (see section 7).
10.3. Possibility of hazardous reactions
None known.
10.4. Conditions to avoid
Heat, freezing.
10.5. Incompatible materials
May cause coagulation: Acids, Multivalent metal salts.
10.6. Hazardous decomposition products
Thermal decomposition generates : Oxides of carbon and nitrogen.
SECTION 11: Toxicological information
11.1. Information on toxicological effects
Acute toxicity
:
Not classified
Vinyl Acrylic Based Polymer, Emulsifier, Surfactant Blend *data for a similar material
LD50 oral rat
> 2000 mg/kg
LD50 dermal rat
> 2000 mg/kg
Skin corrosion/irritation
:
Not classified
Serious eye damage/irritation
:
Not classified
Respiratory or skin sensitization
:
Not classified
Germ cell mutagenicity
:
Not classified
Carcinogenicity
:
Not classified
Reproductive toxicity
:
Not classified
Specific target organ toxicity (single exposure)
:
Not classified
Specific target organ toxicity (repeated
exposure)
:
Liver
Aspiration hazard
:
May be fatal if swallowed and enters airways.
Symptoms/injuries after inhalation
:
Inhalation in high concentrations may cause irritation of the mucous membranes. Aspiration of
this material into the lungs may cause chemical pneumonia or death.
Symptoms/injuries after skin contact
:
Contact may cause irritation.
Symptoms/injuries after eye contact
:
Contact may cause irritation.
Symptoms/injuries after ingestion
:
May be irritating to the mucous membranes.
Chronic symptoms
:
No data available.
SECTION 12: Ecological information
12.1. Toxicity
No additional information available
12.2. Persistence and degradability
No additional information available
12.3. Bioaccumulative potential
No additional information available
12.4. Mobility in soil
No additional information available
12.5. Other adverse effects
No additional information available